ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,014Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 2680

$941K Total Retail Price of All Prescriptions

Rank: 78 out of 2680

648 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 648 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 648 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 16,700 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
FUROSEMIDE 850 818 1 7
WARFARIN SODIUM 797 756 2 12
LEVOTHYROXINE SODIUM 682 621 3 4
METOPROLOL TARTRATE 668 642 4 8
OMEPRAZOLE 617 560 5 2
LISINOPRIL 581 542 6 5
CITALOPRAM HBR 543 483 7 22
SIMVASTATIN 427 356 8 1
HYDROCODONE-ACETAMINOPHEN 415 300 S3 9 13
POLYETHYLENE GLYCOL 3350 365 346 10 55
TRAZODONE HCL 357 307 11 60
SERTRALINE HCL 341 327 12 23
AMLODIPINE BESYLATE 336 304 13 3
MIRTAZAPINE 326 324 14 48
ATENOLOL 252 229 15 14
RISPERIDONE 240 228 16 67
FAMOTIDINE 213 184 17 65
ATORVASTATIN CALCIUM 192 176 18 10
TAMSULOSIN HCL 187 159 19 25
GABAPENTIN 185 136 20 21
HYDROCHLOROTHIAZIDE 181 178 21 9
METFORMIN HCL 181 155 21 6
POTASSIUM CHLORIDE 176 156 23 29
DIGOXIN 167 167 24 59
RANITIDINE HCL 157 136 25 35
PREDNISONE 142 132 26 45
ADVAIR DISKUS 141 125 27 32
NITROGLYCERIN PATCH 140 140 28 171
SPIRIVA 135 131 29 36
LANTUS 132 98 30 70
METOPROLOL SUCCINATE 124 98 31 11
ALLOPURINOL 120 116 32 42
OXYBUTYNIN CHLORIDE ER 119 115 33 135
CARVEDILOL 119 116 33 27
IPRATROPIUM-ALBUTEROL 119 117 33 110
KLOR-CON M10 117 117 36 185
DONEPEZIL HCL 114 112 37 28
ENALAPRIL MALEATE 109 94 38 24
QUETIAPINE FUMARATE 106 98 39 72
CIPROFLOXACIN HCL 105 100 40 85
LOSARTAN POTASSIUM 104 100 41 18
TRAMADOL HCL 102 95 42 33
TAMIFLU 99 94 43 136
MELOXICAM 99 88 43 50
FINASTERIDE 97 93 45 80
TRIAMCINOLONE ACETONIDE 96 93 46 138
GLYBURIDE 94 89 R 47 66
CARBIDOPA-LEVODOPA 94 94 47 88
KLOR-CON M20 90 88 49 101
DIOVAN 89 89 50 26
PROPRANOLOL HCL 88 69 51 158
METFORMIN HCL ER 86 73 52 53
NEXIUM 86 74 52 19
GLIPIZIDE 83 83 54 71
OXYCODONE HCL 83 21 S2 54 93
SPIRONOLACTONE 82 78 56 86
PRAVASTATIN SODIUM 81 76 57 16
DILTIAZEM 24HR CD 80 80 58 148
CEPHALEXIN 79 72 59 132
PANTOPRAZOLE SODIUM 78 61 60 44
HYDROXYZINE HCL 76 69 R 61 212
FLUTICASONE PROPIONATE 74 59 62 38
PHENYTOIN SODIUM EXTENDED 73 54 63 207
JANUVIA 68 68 64 34
IBUPROFEN 64 33 65 63
FLUOXETINE HCL 64 33 65 76
ZOLPIDEM TARTRATE 63 58 67 17
SULFAMETHOXAZOLE-TRIMETHOPRIM 60 55 68 137
NOVOLOG 60 60 68 159
DOXYCYCLINE HYCLATE 60 58 68 237
BACLOFEN 59 47 71 123
SOTALOL 57 53 72 533
ACETIC ACID 57 57 72 533
LATANOPROST 57 57 72 195
MORPHINE SULFATE ER 55 0 S2 75 209
ESCITALOPRAM OXALATE 55 46 75 82
ZOSTAVAX 55 52 75 229
NOVOLIN N 55 55 75 279
CYMBALTA 54 42 79 56
AMITRIPTYLINE HCL 53 28 R 80 113
MECLIZINE HCL 53 49 80 105
CARBAMAZEPINE 51 51 82 184
HALOPERIDOL 51 49 82 153
PROAIR HFA 51 23 82 52
NAMENDA 51 51 82 43
LIPITOR 50 40 86 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.